Colorectal cancer. Combining drug therapies to improve treatment efficacy in metastatic colorectal cancer
- PMID: 25688054
- DOI: 10.1038/nrgastro.2015.29
Colorectal cancer. Combining drug therapies to improve treatment efficacy in metastatic colorectal cancer
Comment on
-
IGF2 is an actionable target that identifies a distinct subpopulation of colorectal cancer patients with marginal response to anti-EGFR therapies.Sci Transl Med. 2015 Jan 28;7(272):272ra12. doi: 10.1126/scitranslmed.3010445. Sci Transl Med. 2015. PMID: 25632036
References
-
- Sci Transl Med. 2015 Jan 28;7(272):272ra12 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical